AKAN
Akanda Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$3.22
+9.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.16x
- Price / sales
- 6.75x
- Price / cash flow
- -0.26x
Enterprise value
- Enterprise value
- $14.3M
- EV / sales
- 55.29x
- EV / EBITDA
- -2.94x
- EV / EBIT
- -2.73x
- Market cap
- $1.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025